scispace - formally typeset
W

Wanpei Cai

Researcher at National University of Singapore

Publications -  10
Citations -  679

Wanpei Cai is an academic researcher from National University of Singapore. The author has contributed to research in topics: Metastasis & Cancer. The author has an hindex of 8, co-authored 10 publications receiving 499 citations.

Papers
More filters
Journal ArticleDOI

Triple negative breast cancer in Asia: An insider's view.

TL;DR: This review encapsulates the studies conducted on TNBC patients in Asian population and elucidates the similarities and differences between these two regions to facilitate the development of better treatment strategies to combat TNBC.
Journal ArticleDOI

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?

TL;DR: The common dysregulation of PI3K/Akt/mTOR pathway in GC and the various types of single or dual pathway inhibitors under development that might have a superior role in GC treatment are reviewed and the recent developments in identification of predictive biomarkers are summarized.
Journal ArticleDOI

Secreted frizzled related proteins: Implications in cancers.

TL;DR: This review comprehensively covers all the available information on the role of SFRP molecules in various human cancers and identifies potential tools in combating Wnt-driven tumorigenesis.
Journal ArticleDOI

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

TL;DR: This review provides a comprehensive overview of microRNAs with established functional relevance in breast cancer, their established target genes and resulting cellular phenotype, and the role and application of circulating miRNAs in breast cancers.
Journal ArticleDOI

Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.

TL;DR: Next-generation sequencing data obtained from public portals and reviewing existing literature are analyzed to provide new insights on the potential of DEAD/H-box helicases to act as pharmacological drug targets in cancers and the potential small molecule inhibitors of helicases and their therapeutic value are discussed.